REFERENCES
- The New York Times Commends Memorial Sloan Kettering's Stance on a Costly Cancer Drug. Available at: http:// www.mskcc.org/blog/new-york-times-commends-msk-s-stance-costly-drug. Accessed September 30, 2014.
- Experts in Chronic Myeloid Leukemia. The price of drugs for chronic myeloid leukemia (CML) is a reflection of unsustainable prices of cancer drugs: from the perspective of a large group of CML experts. Blood 2013;121:4439–42.